比较Obtura血管闭合装置与人工压迫在经股动脉介入术后实现止血的效果:一项随机研究
这项前瞻性、随机、对照、多中心试验将268例经股动脉导管插入术患者按1:1随机分为Obtura血管闭合装置组与人工压迫组,比较两组的安全性和有效性。Obtura组止血时间和下床活动时间均显著短于人工压迫组,两组技术成功率和装置释放成功率均为100%,随访期间无入路部位并发症。
要点
- Obtura组止血时间3.26±3.39分钟,人工压迫组23.95±8.24分钟,差异有统计学意义(p<0.0001)。
- Obtura组下床活动时间155.44±125.32分钟,人工压迫组723.84±197.98分钟,差异有统计学意义(p<0.0001)。
- 两组技术成功率和装置释放成功率均为100%,随访期间无入路部位并发症。
核心结论
- 研究表明Obtura血管闭合装置具有良好的安全性和有效性,与人工压迫相比止血时间和下床活动时间显著更短。
研究设计与样本
- 前瞻性、随机、对照、多中心试验,将268例经股动脉导管插入术患者按1:1随机分为Obtura血管闭合装置组(n=134)和人工压迫组(n=134)。
主要发现
- Obtura组止血时间3.26±3.39分钟,人工压迫组23.95±8.24分钟,差异有统计学意义(p<0.0001)。
- Obtura组下床活动时间155.44±125.32分钟,人工压迫组723.84±197.98分钟,差异有统计学意义(p<0.0001)。
- 两组技术成功率和装置释放成功率均为100%。
- Obtura组血肿4例(3%),人工压迫组6例(4.5%);两组术后动脉假性动脉瘤各1例(0.7%),均成功处理并出院,无进一步并发症。
- 2周、1个月和3个月随访时未观察到入路部位并发症(再出血、感染、动静脉瘘和一过性入路部位神经损伤)。
临床怎么用
- 在经股动脉导管插入术患者中,Obtura血管闭合装置可在装置成功植入后更快实现止血,减少出血等并发症,并更快下床活动。
- 在有效性方面,Obtura血管闭合装置在实现早期止血方面优于人工压迫,并获得更高的技术和装置释放成功率。
- Obtura血管闭合装置不需要扩大穿过组织的路径,使用现有动脉鞘作为通道,部署时不会使患者入路部位感到不适。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This trial was designed and aimed to compare safety and efficacy of Obtura™ vascular closure device (VCD) to manual compression (MC) among patients undergoing transfemoral catheterization. MATERIAL AND METHODS: This prospective, randomized, controlled, multicenter trial of Obtura VCD against MC randomized patients in 1:1 (n=268; 134:134) ratio. Safety and efficacy were measured by primary endpoints (time to hemostasis [TTH] and deployment success) and secondary endpoints which included technical success, device-related adverse events, and time to ambulation (TTA). RESULTS: The procedural access using right femoral artery was performed in 95.52% of patients in Obtura VCD versus 96.27% in standard MC method, whereas 2.99% of patients in each group underwent left femoral access. Bilateral access was performed in 1.49% (n=2) versus 0.75% (n=1) in Obtura VCD versus MC, respectively. Both the technical success and deployment success were 100%. Patients in Obtura VCD group had shorter TTH (3.26±3.39 vs 23.95±8.24 minutes; p<0.0001) and TTA (155.44±125.32 vs 723.84±197.98 minutes; p<0.0001) than MC group. No access site complications (re-bleeding, infection, arteriovenous fistula, and transient access site nerve injury) were noted at 2-week, 1-month, and 3-month follow-ups. There were 4 (3%) and 6 (4.5%) cases of hematoma, respectively, in Obtura VCD versus MC and 1 case (0.7%) of post-procedural arterial pseudoaneurysm each in both the groups which were successfully resolved and patients were discharged with no further complications. Further follow-up was without any adverse events. CONCLUSIONS: The study demonstrated favorable safety and efficacy of Obtura™ VCD with a significantly short TTH and TTA compared to MC.Clinical ImpactIn patients undergoing cardiac catheterization, vascular closure devices (VCDs) can achieve hemostasis faster after successful implantation of the device with fewer complications such as bleeding and ambulation can be achieved faster. In terms of effectiveness, Obtura VCD was found to be better than manual compression in achieving early hemostasis and higher technical and deployment success was accomplished. Obtura VCD does not require enlargement of the route through the tissues, uses the same existing arterial sheath as its conduit, and does not cause patients' access sites to feel uncomfortable while it is being deployed.
引用
- Devasia T, Premchand RK, Sinha SK, et al. Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study. J Endovasc Ther. 2024. PMID: 39044646. doi:10.1177/15266028241258662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。